ACIP Immunization Schedules Issued for Children, Adults
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 16, 2025 -- The Advisory Committee on Immunization Practices (ACIP)-approved immunization schedules for children and adolescents and for adults for 2025 have been published in the Jan. 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Anindita N. Issa, M.D., from the CDC in Atlanta, and colleagues issued the ACIP-approved "Recommended Immunization Schedule for Children and Adolescents Ages 18 Years or Younger, United States, 2025," which provides a summary of current recommendations for vaccinating children and adolescents. The authors note that changes in the 2025 immunization schedule compared with the 2024 schedule include new and updated recommendations for the COVID-19 vaccine, Haemophilus influenzae type b vaccines, influenza vaccines, and meningococcal serogroup B vaccines. Recommended influenza vaccines have been changed from the quadrivalent to the trivalent formulation.
A. Patricia Wodi, M.D., also from the CDC, and colleagues issued the ACIP-approved "Recommended Immunization Schedule for Adults Ages 19 Years or Older, United States, 2025," which provides a summary of current recommendations for adult vaccinations. The authors note that vaccine-specific changes to the 2025 schedule compared with the 2024 schedule include new and updated recommendations for the COVID-19 vaccine, influenza vaccines, meningococcal serogroup B vaccines, pneumococcal conjugate vaccines, and respiratory syncytial virus vaccines. Recommended influenza vaccines have been changed from the quadrivalent to the trivalent formulation.
"For vaccines that appear in both the adult immunization schedule and the child and adolescent immunization schedule, the language in both schedules has been harmonized to the greatest extent possible," Wodi and colleagues write.
One author from both studies disclosed ties to the publishing industry.
ACIP Schedule for Children and Adolescents
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-18 00:00
Read more
- Study Compares Single-Inhaler Triple Therapies for Treatment of COPD
- More Activity, Less Risk: Tell Your MD How Much You Move
- People With Lupus Are At Risk for This Type of Heart Disease
- Ready-to-Eat Broccoli Pulled from Walmart Shelves Due to Listeria Risk
- Phone App May Help Treat Opioid Use Disorder, Data Suggests
- Sapience Therapeutics Receives FDA Orphan Drug Designation for ST316, a First-in-Class β-catenin Antagonist, for the Treatment of Familial Adenomatous Polyposis (FAP)
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions